Blog

Amy C. Moore: LUNGevity Foundation International Lung Cancer Survivorship Conference

Photo taken from Amy C. Moore/LinkedIn

Jun 13, 2024, 10:46

Amy C. Moore: LUNGevity Foundation International Lung Cancer Survivorship Conference

Amy C. Moore, VP of Global Engagement and Patient Partnerships, LUNGevity Foundation, shared a post on LinkedIn:

“It has been 20 years since the discovery of the EGFR mutation ushered in the era of precision medicine for lung cancer. We are celebrating this important milestone and many more research advances at this year’s LUNGevity Foundation International Lung Cancer Survivorship Conference (ILCSC24), happening virtually Sept 20 – 21. Sign up to get notified when registration opens”

Read further.
Source: Amy C. Moore/LinkedIn

Amy C. Moore cancer EGFR-mutation ILCSC24 International Lung Cancer Survivorship Conference lung cancer research LUNGevity Foundation OncoDaily Oncology Precision Medicine registration notification research advances survivorship virtual conference

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage